Moderna Advances Early Hantavirus Vaccine Research Ahead of Cruise-Outbreak Scrutiny
Moderna says it’s pursuing early-stage hantavirus vaccine work with the US Army Medical Research Institute of Infectious Diseases and Korea University’s Vaccine Innovation Center, begun before the Hondius cruise-ship outbreak, as public health officials say the immediate risk remains limited while the company develops countermeasures.